20-24 June, 2026 Kuala Lumpur
| 2-P | Correct matching process "donor/blood unit/test tube": new automatic system with PJM RFID labels on test tubes at Brescia Blood Bank (BBB) | Susanna Bresciani | |
| 3-P | Are indicators used to evaluate low- and middle-income country progress in transfusion medicine the right ones? | Cees Smit Sibinga | |
| 5-P | Transfusion Service–Led Coordination Pathway for Patients with Suspected IgA Deficiency Across Two Hospitals and Blood Centres | Rishiraj Sinha | |
| 7-P | "Evaluating Transfusion Appropriateness and Safety: A Year-Long Audit of Blood Component Therapy in a Tertiary Care Hospital in Dhaka" | Sonia Shormin Miah | |
| 8-P | Retrospective Analysis of Manual Verification with the Tube Method following Automated ABO Blood Grouping in a Korean University Hospital: Toward Establishing an Efficient Stepwise Testing Protocol | Jeong Won Shin | |
| 11-P | A low-middle income country (LMIC) scalable system reform: Transitioning a fragmented replacement donation-based system to global standards of centralized blood banking | Shabneez Hussain | |
| 12-P | Evaluation of the Effectiveness of Establishing the National Bone Marrow Donor Registry of the Republic of Kazakhstan (2021–2025) | Aruzhan Tolybayeva | |
| 16-P | Validation of the requirement for the investigation of the discrepancy results between Pilot Tube Serology and Blood Bag donation | Norshuhaidah Jamaludin | |
| 22-P | Low-cost system redesigns using human-factor principles to improve safety in a resource-limited blood centre like Shisa Kanko | Arun V J | |
| 24-P | Triple versus Double Blood Bag Systems – Cost, Waste, and Carbon Emission: Impact Analysis in a Single Regional Blood Center in the Philippines | Sherjan Pangato | |
| 27-P | Bridging The Gap: Assessing the impact of scientific skills gaps in blood component processing | Mushtaq Abdi | |
| 28-P | From one hospital to a health system: Rapid scale-up of functional hospital transfusion committees in Cameroon | BEUKOU FONKOU HYGIN STEVE | |
| 29-P | Strengthening transfusion medicine expertise through Area of Interest (AOI) In Malaysia: current status, gaps, and way forward | Thane Moze Darumalinggam | |
| 30-P | Unfortunate Ignorance on Bedside Transfusion Safety & Prevention Strategy Turkish Experience | Nusret Nuri Solaz | |
| 34-P | Building a safe blood transfusion system through structured training of non-medical staff: a 20-year experience from Pakistan | Maeesa Wadood | |
| 35-P | Training Needs Assessment for Transitioning from Cesium-137 to X-ray Blood Irradiators in African Countries | Mostafa Kofi | |
| 37-P | Transfusion Medicine Education in Japanese Medical Schools: Struggling in Transition Under Structural Constraints – Comparison Between 2009 and 2025 | Tomohiko Sato | |
| 39-P | International blood donation education through student-led exchange: The AMSEP JIKEI 2025 experience between Japan and Indonesia | Chika Ohara | |
| 41-P | Capacity Gaps, Accreditation, and Predictions for African Blood Banking Professionals (2026–2040) | Mostafa Kofi | |
| 42-P | Standardization Gaps and Workforce Competencies Among Blood Banking Professionals in Africa: A Continental Systems Analysis | Mostafa Kofi | |
| 45-P | Strengthening Blood Transfusion Services in Africa: cooperation activities of the European School of Transfusion Medicine in Libya and Guinea-Bissau | Vincenzo De Angelis | |
| 48-P | Impact of Structured Educational Interventions on Bedside Transfusion Practices and Donor Safety Awareness: An Integrated Knowledge and KAP Assessment from a Tertiary Care Centre in North India | Ankit Jain | |
| 50-P | Risk-based implementation model with sequential auditable critical milestones to standardize technology transitions in a high-complexity university hospital blood bank | Erika Milena Granados Ferrer | |
| 51-P | Plasma-Derived Therapies in Mexico: Why Recovered Plasma Cannot Sustain Industrial Self-Sufficiency | Juan Manuel Cisneros Carrasco | |
| 54-P | Towards Plasma-Derived Medicinal Product (PDMP) Self-Sufficiency in Sri Lanka: Assessment of International Models, Recovered Plasma Availability and Quality Assurance | Nandika Roshan | |
| 62-P | A Survey on transfusion therapy in obstetrics, focusing on geographical factors | Asashi Tanaka | |
| 63-P | A retrospective analysis of the antigen-negative red blood cell supply conducted at a single center in China | Aiping Zhao | |
| 65-P | Utilisation and Inventory Challenges of Group O RhD-Negative Red Cell Units in a Secondary Hospital: Experience from Taiping Hospital, Malaysia | Nurulraihan Mohamed Zawawi | |
| 67-P | Strategy for Precision Blood Supply for Transfusion-dependent Thalassemia Patients | Hsiao-Fen Chen | |
| 69-P | Interinstitutional perspectives on usage of fibrinogen concentrates and cryoprecipitate | Cindy Tay | |
| 70-P | Blood supply and covid-19: disaster or blessing in disguise? | Cees Smit Sibinga | |
| 71-P | Audit of Blood Supply and Utilization in a Hospital Blood Bank | Hannah Olawumi | |
| 73-P | From Waste to Worth: Strengthening Blood Product Management in Hospital Sultan Idris Shah, Serdang | Nur Amrina Roslan | |
| 75-P | Digital Transformation in Blood Stewardship: Sustaining Ultra-Low Red Cell Expiry Over Seven Years in a High-Volume Tertiary Hospital | ZANARIAH BINTI KASSIM | |
| 79-P | Audit of RBC Components Returned to the Blood Centre at a Tertiary Referral Hospital in India | Sheenam Thakkar | |
| 81-P | Guideline dissemination and blood component utilization in Japanese hospitals | Shinichiro Fujiwara | |
| 83-P | Seasonal Variability in the Issuance of Blood Components: A Three-Year Analysis of the Scientific and Production Center for Transfusiology, Astana | Liliya Yun | |
| 84-P | Reducing Blood Product Wastage at a Tertiary Care Cancer Center Through AABB-Guided Patient Blood Management | Lubna Al Zadjali | |
| 85-P | Blood Unit Collection and Prevalence of Blood Groups Among Donors at the Newly Established SQCCCRC | Shihab Al Makhmari | |
| 99-P | Facility-Level Disparities in Blood Grouping Serology EQA Performance: Descriptive Analysis year 2024 from Tanzania | Don-Dolcetto Ngilisho | |
| 100-P | TRACE-PNG: Uncovering the hidden burden of red cell exposure and missed opportunities for antibody screening in Papua New Guinea. | Natasha Philip | |
| 102-P | Impact of inventory control measures on red blood cell expiry rates in a new tertiary care hospital | Nur Aisyah Umairah Nawi | |
| 103-P | Association Between Perioperative Red Blood Cell Transfusion and Postoperative Sepsis Outcomes: A Retrospective Cohort Study Using ACS-NSQIP, A Prospective Multinational Registry | Asmi Agarwal | |
| 104-P | Strategic Inventory Reserves for Improved Blood Availability Using a PDCA Quality Improvement Framework | Chippy C S | |
| 105-P | Bridging the Gap: Enhancing blood unit quality through integrated team coordination | Azmanira Aziz | |
| 109-P | Improving Blood Transfusion Safety through Quality Indicators: A Hemovigilance Approach at PIMS | Drfarwa Sijjeel | |
| 112-P | Examining Compliance with Massive Haemorrhage Protocol Practices at a Level I Trauma Centre | Matthew Olejarz | |
| 114-P | Innovative Application of RFID-Based Intelligent Closed-Loop Management in Automated Blood Specimen Handover | Jie Zhao | |
| 116-P | Clinical Audit on Evaluation of Blood Requisition Forms Submitted to Blood Bank Hospital Sultan Haji Ahmad Shah, Temerloh | Siti Marlina Misran | |
| 117-P | Blood Sample Rejection in a Transfusion Medicine Laboratory: Data Analysis from a Lead Cluster Hospital in Northern Malaysia | Syahirah Mohamed Yusoff | |
| 118-P | Turnaround time monitoring for red blood cell provision in a newly established adult haematology day care centre | Halimatun Radziah Othman | |
| 119-P | Strengthening transfusion safety in a resource-limited blood centre through stepwise donor screening audit and sustained quality improvement | ARUN V J | |
| 120-P | Life Cycle Assessment (LCA) of Macopharma´s SSP4025U SSP+ Reference: A Step Toward Sustainable Practices | Quentin Brebant | |
| 124-P | Evaluation and Improvement Strategy of Laboratory Turnaround Time of Group, Screen & Hold in Tertiary Care Teaching Hospital in Malaysia | Khalid Zalizah | |
| 136-P | Disaster response to the Tai Po Fire – a reflection of the roles and responsibilities of Blood Transfusion Service to meet public expectation | Shun Yin Kong | |
| 137-P | Public and stakeholder perspectives on ethical innovation beyond transfusion: A mixed methods PPIE study of human platelet lysate within the blood supply chain | michael.cahillane@wales.nhs.uk Cahillane | |
| 138-P | Understanding beliefs Aboriginal and Torres Strait Islander Peoples have about blood donation and blood transfusion for Culturally Safe provision of blood services | Maree Perry | |
| 140-P | I hope it would be available to anybody who needs it: Exploring donor perspectives on laboratory-grown red blood cells | Rachel Thorpe | |
| 141-P | Quality of life, financial burden and perceived stress among caregivers of transfusion-dependent thalassemia patients in a metropolitan care centre in India | Gaurav Naik | |
| 143-P | Accepting blood donors for source plasma with no sexual activity restrictions; the world first Australian experience of the first six months post implementation | Anthea Cheng | |
| 146-P | Reintegrating Deferred Donors: Clinical and Public Health Impact of Donor Wellness Clinics in Optimizing India´s Blood Donation Services | Sehrish Chaudhary | |
| 148-P | From hesitation to participation: Impact of educational and motivational interventions on voluntary blood donation among medical students in Pakistan | Fahad Ahmed | |
| 159-P | From Incidental Finding to Donor Loss: The Hidden Impact of DAT Positivity | Anis Zarina Zarini | |
| 160-P | Optimization of the Donor Selection Process Using a Real-Time Support Channel and Its Impact on Deferral Reduction | Michel-Andres Michel-Andres | |
| 163-P | Barriers and facilitators of apheresis platelet donation: a profile from a Malaysian tertiary centre | Lois Low Xin Ning | |
| 170-P | Target based strategy to increase blood donation during the month of Ramadhan in Jabatan Perubatan Transfusi Darah, Hospital Tengku Ampuan Rahimah | Nur Syahirah Abdul Rahim | |
| 172-P | Perception of Blood Donation Among Medical Students | Michel-Andres Garcia-Otalora | |
| 174-P | Comparative Evaluation of Point-of-Care Hemoglobin and Hematocrit Measurement Devices Using Venous Blood Samples | Christopher Pöhlmann | |
| 177-P | Missed Opportunities in Blood Donation: Donor Deferral Experience from Taiping Hospital, Malaysia | Nurulraihan Mohamed Zawawi | |
| 178-P | Addressing the Youth Blood Donor Challenges: Effectiveness of Pop Culture Integration in Blood Donation Campaigns in Singapore | Nurliana Omar | |
| 179-P | Research on factors influencing voluntary non-remunerated blood donors satisfaction based on grounded theory | Tingting Hu | |
| 181-P | Use of Artificial Intelligence in Blood Donor Selection: Performance Comparison of Large Language Models | Michel-Andres Garcia-Otalora | |
| 183-P | The Inverted Pyramid: A 6-Year Longitudinal Retrospective Analysis of the "Demographic Debt" in Blood Donor Sustainability in Hospital Sultanah Aminah Johor Bahru | Faizah Hassan | |
| 185-P | Beyond blood donation camps: using community engagement programs to improve blood collection and donor retention | Mohd Redzuan Abdullah | |
| 186-P | Effect of virtual reality during blood donation on donor mood states: a pilot study using the BRUMS scale | ARUN V J | |
| 187-P | Development and Validation of a Blood Donation Barriers Scale Among Chinese College Students | Huahua Hu | |
| 188-P | Success Story of a Community Based Blood Donation Suite in the East coast of Malaysia | Nor Suriana Binti Zakaria | |
| 191-P | "Pop-up" blood donation sites in urban shopping malls as an option to recruit younger donors in urban areas and to ameliorate demographic challenges | Lambros Kordelas | |
| 192-P | Donor status–specific patterns of factors associated with blood donation intention among young adults in Japan, an advanced aging society | Yutaro Tsukamoto | |
| 193-P | Blood donor knowledge, trust, and acceptability of voluntary source plasma donation in Sri Lanka | Nandika Roshan | |
| 195-P | From Awareness to Action: Assessing the Efficacy of Community-Based Promotional Strategies in Mobilizing Blood Donor Participation | Syamimi Afiqah Shahlal | |
| 196-P | Blood Donor Recruitment and Retention Analysis: A Five-Year Strategic Review (2021-2025) | Khairawati Binte Harip | |
| 198-P | Eighty-five percent non-return following low haemoglobin deferral as a silent threat to transfusion sustainability in Colombia | Michel-Andres Garcia-Otalora | |
| 199-P | Evaluation of Donor Deferral Causes in Whole Blood Donors | Kalpesh Chawan | |
| 200-P | From Donors to Co-Creators: Redesigning the Blood and Plasma Donation Experience Through Human-Centered | Nuria Nogues | |
| 201-P | Deferral of blood donors in the colombian caribbean region between 2017 and 2023: a contrast with the national average | Michel-Andres Garcia-Otalora | |
| 202-P | LGBTQ+ affiliated blood drives engage younger, more diverse, and first-time blood donors | Waseem Anani | |
| 203-P | Impact of Gift Provision on Six-Month Return Rates Among Blood Donors | SHARMILA MANIAN | |
| 205-P | Assessment of Donor Deferral Patterns and Evaluation of the Returning Deferral Donors in Sri Lanka | Pitiyage Nandika Roshan Somasiri | |
| 206-P | Mapping Donor Trajectories in Blood and Plasma Donation: Predictive Modeling and Explainable Insights for Retention Strategies | Nuria Ribas | |
| 207-P | A New Concept for Promoting Blood Donation in the Republic of Kazakhstan | Alma Demeuova | |
| 208-P | Supporting donor recruitment and retention through digital engagement: a multi-centre observational study | Paula Gal | |
| 209-P | Performance evaluation of blood donor selectors in Colombia: Is the process aligned with the national technical guideline? | Michel-Andres Garcia-Otalora | |
| 210-P | Fostering a culture of donation with African, Caribbean, and Black communities | Jennie Haw | |
| 213-P | Non-Communicable Disease (NCD) Risk in an Apparently Healthy Donor Population in the National Blood Centre, Kuala Lumpur | Alvina Lau | |
| 217-P | Donor safety and return following the shortened whole blood donation interval: A multicenter, retrospective cohort study evaluating the pilot policy in China | Yuwei Hu | |
| 219-P | Iron deficiency and plateletpheresis associated lymphopenia increase with donation frequency in plateletpheresis donors | April Davis | |
| 224-P | Therapeutic Venesection as a Core Treatment Strategy for Polycythemia and Iron Overload Disorders: A Single-Center Experience | Ayat Osman | |
| 225-P | Iron Status Among Malaysian Whole Blood Donors: A Single-Centre Study | CHRISTINA LEE LAI LING | |
| 228-P | Evaluation of Blood Donor Deferral During Routine Pre-Donation Medical Screening: A Five-Year Study at a Regional Blood Center in Swat (2021–2025) | Sultan Ahmad | |
| 238-P | Knowledge and Perception of Blood Safety Among Malaysian Medical Students: Gaps, Predictors, and Educational Imperatives | Nur Mazidah Shahidan | |
| 239-P | Reticulocyte haemoglobin (Ret-He) as a surrogate marker of iron depletion in whole blood donors. | Ahmad Makmom Muhammad Amir Rasyid | |
| 240-P | Prevalence of Elevated Haemoglobin Levels Among Blood Donors in Singapore: A Three-Year Retrospective Analysis (2023–2025) | Kyi Kyi San | |
| 242-P | Hemovigilance Trends and Donor Satisfaction in Mobile Plasmapheresis: Outcomes from a Decentralized Collection Program | Nuria Ribas | |
| 246-P | Iron status of first time and repeat blood donors in Ibadan, Nigeria | Foluke Fasola | |
| 247-P | Hidden iron deficiency among frequent plateletpheresis donors despite normal hemoglobin levels | wadha aldossari | |
| 249-P | Iron supplementation for whole blood, red cell, and plasma donors, to reduce deferral and anaemia. | Susan Brunskill | |
| 251-P | Effects of Adjusting the Upper Age Limit for Voluntary Blood Donation on Donation Safety and Donation Behavior: A Multicenter Retrospective Clinical Study | Chenying Wang | |
| 252-P | The Outcomes of Female Blood Donation Campaign in North Al Sharqiya, Oman: A Prospective Analysis | Musleh Al Musalhi | |
| 254-P | Exploring preferences of blood donors with high ferritin for genetic testing through blood donation | Rachel Thorpe | |
| 259-P | Analysis of Latent Iron Deficiency Among Blood and Blood Component Donors | Ala Novik | |
| 261-P | Uplifting pre-donation haemoglobin cutoff from 11.5 to 12 g/dL for female blood donors in Hong Kong – a tectonic change in practice with over 50 years of history | Shun Yin Kong | |
| 264-P | EFFECT OF EXTENDED CBC PARAMETERS ON PLATELET APHERESIS EFFICIENCY AND PRODUCT QUALITY | Zharas Bibekov | |
| 265-P | Donor Voices, Future Choices: A Cross-Sectional Descriptive Survey Understanding the Willingness for Allogeneic Leukapheresis Donation Amongst Lifeblood Donors | Justine ODonovan | |
| 269-P | Comparison of platelet yield and machine-related parameters among three platelet apheresis machines. | Ambika Nakulan | |
| 273-P | Qualitative Feedback from Plasma Donors on the Methodology of a Future Prospective Cohort Study | Michelle Fransen | |
| 274-P | Improving Blood Collection Quality at the Newly Established SQCCCRC: Tracking Non Conformance and Safety | Shihab Al Makhmari | |
| 275-P | IT-based active surveillance system for apheresis collections | Marcia Cardoso | |
| 277-P | Risk factors for citrate–induced paresthesia in apheresis donors | Manuel Gutiérrez de Ravé | |
| 278-P | Temporal and demographic determinants of adverse events in whole blood donation | Aidos Kenzhin | |
| 282-P | Patterns and Prevention of Whole Blood Donor Adverse Reactions: A Three-Year Hemovigilance Analysis with KAP Assessment of Blood Centre Staff | Ankit Jain | |
| 284-P | Impact of the implementation of a Blood Bank Information System on donor adverse event reporting, experience from the National Blood Transfusion Center, Albania | Riana Gjeta | |
| 285-P | Safety of Apheresis Donation Compared to Whole Blood Donation in Singapore | Grace Kam | |
| 286-P | Analytical performance evaluation of a multiplexed serology assay designed to support a nationwide repeat blood donor based respiratory virus serosurveillance program | Marion Lanteri | |
| 288-P | Per- and polyfluoroalkyl (PFAS) concentrations in high and low frequency donors | Ole Birger Pedersen | |
| 289-P | Surveillance of respiratory virus infections using surveys of a cohort of United States blood donors initiated in 2025 | Bryan Spencer | |
| 290-P | ABO and Rhesus antigens prevalence among blood donors born in Cluj county, Romania | Marc-Tudor Damian | |
| 292-P | Longitudinal Serological Surveillance Identifies Recurrent SARS-CoV-2 and other Respiratory Virus Infections in Frequent Plasma Donors | Clara Di Germanio | |
| 293-P | Metabolic risk screening in adolescent blood donors. | Stephen Eason | |
| 298-P | Three-Buffy-Coat Pooled Platelet Concentrates: Establishing Clinical Functionality, Yield Compliance and Inventory Benefits in Routine Manufacture from a Welsh Perspective | Michael Cahillane | |
| 301-P | Blood compatibility and safety performance of a plasticiser-free SEBS/PP blood bag material | Srimala Sreekantan | |
| 303-P | Impact of Weekly Mixing of Red Cell Concentrates on Storage Quality: A Comparative Study | Anaïs LAGRANGE | |
| 304-P | ´Method Validation and Quality Control Comparison of Blood Components Prepared by Inline Filtration Versus Fully Automated Processing´ | Pavarit Arayasukawat | |
| 307-P | In vitro quality of x-ray irradiated RBCs in PAGGS-M prepared in non-DEHP bag systems | Ute Gravemann | |
| 311-P | Extracellular vesicles in apheresis and cryopreserved platelet components contain protein biological response modifiers | Lauren Litchfield | |
| 313-P | Lipidomic profile of extracellular vesicles in fresh versus stored buffy coat platelet components | Lauren Litchfield | |
| 315-P | Quality Assessment of Leucocyte-Reduced Red Cell Concentrates Following Post-Storage Filtration in Aged Blood Units | Shanneen Malusay | |
| 317-P | Analysis of the reasons for declaring blood components unfit for clinical use | Saniya Abdrakhmanova | |
| 321-P | Platelet Inventory Management : An Analysis of Wastage Patterns in a Tertiary Hospital in East Malaysia | Ttarcini Engatramana | |
| 334-P | Performance evaluation of a fluorescence-based cell counting method for residual white blood cell enumeration in leukoreduced red cell components | Samsol Kamal Mohd Bahari | |
| 335-P | Assessing the quality of apheresis-derived red cell concentrates stored in AS-3 additive solution | Marcia Cardoso | |
| 337-P | Standardization of the Romanian Blood Transfusion Services— Deployment of whole blood automation | Marcia Cardoso | |
| 338-P | To evaluate the efficacy of post-thawed cryoprecipitate in cardiac bleeding: A retrospective single center study | Nor Syqilah Nabilah Mohd Sadek | |
| 339-P | Quality Monitoring of Blood Components: Descriptive Analysis and Standard Comparison at a Tertiary care hospital blood center, Sri Lanka | Trileeshiya Withanawasam | |
| 343-P | Evaluation of an Analyzer with Blood Bank Mode for Counting Residual Red Blood Cells in Plasma and Platelet Components Prior to Pathogen Inactivation | Lidice Bernardo-Reyes | |
| 350-P | In vitro evaluation of Red Cell Concentrates, Platelets recovered pooled and Plasma prepared and stored in non-DEHP bags from whole blood collected in full non-DEHP In-Line system | Laurent Aoustin | |
| 351-P | Evaluation of Pooled Buffy Coat Platelets Stored in SSP+ PAS : Experience at the Institute for Blood Transfusion of Montenegro | Jelena Zonji&263; | |
| 354-P | ABO Blood Group Influences Baseline Clotting Kinetics but Not Storage Stability of Apheresis Platelets | Susan Shea | |
| 355-P | Lessons learned from a systematic review of lab (in vitro) studies – possible improvements in the reporting of laboratory-based studies | Catherine Kimber | |
| 356-P | Generation of GMP-grade and isoagglutinin depleted "off-the-clot" human serum from pooled Buffy Coats | Matthias Johnsen | |
| 360-P | Evaluation of the fibrinogen recovery rate as a key quality indicator for in-house cryoprecipitate preparation | Ryosei Murai | |
| 361-P | Safety of autologous fibrin glue production using the CryoSeal system | Mai Matsubara | |
| 362-P | The majority of male blood donors of blood group A show low or very low anti B-titer which are mostly stable during a follow-up period of one year | Lambros Kordelas | |
| 377-P | Integration of Pathogen Reduction Technology into Operational Plasma Production: An Innovative Approach to Plasma Pooling | Roya Pasha | |
| 379-P | Differences in the effects of HIF-PHI due to gender differences in CKD with renal anemia | AKIRA MIMA | |
| 382-P | Downscaling to small-volume storage bags supports platelet quality and efficient use of cold-stored platelets for preclinical studies. | Janhavi Mahajan | |
| 385-P | Enhancement of serum-derived albumin´s cryoprotective mechanism by selective modification of its ionisable residues | Thomas Bailey-Schmidt | |
| 386-P | Development, Standardization, and Safety Assessment of Human Platelet Lysate from Expired Allogeneic Platelet Concentrates in the Department of Transfusion Medicine, Universiti Malaya Medical Centre | Wan Imron Faizal Wan Nazatul Shima | |
| 388-P | A Novel Supercritical CO2-Modified Leukoreduction Filter with Enhanced Microparticle Removal | Yong-Guei Chen | |
| 390-P | Antioxidant-Loaded Nanomaterials For Extending Red Blood Cell Shelf Life | Afnan Jabr Alsulami | |
| 391-P | Agitation induces aggregate formation in cold-stored platelets during extended storage in platelet additive solution. | Janhavi Mahajan | |
| 394-P | Recovery of non-transfusional hemocomponents as a resource for home care: a circular economy model in transfusion medicine | Giuseppa Tancredi | |
| 395-P | Human platelet lysate from time-expired pooled platelet concentrates: Sustainable manufacture, quality, growth-factor mechanisms and functional relevance towards standardised blood-service supply | Michael Cahillane | |
| 396-P | Key Baseline Parameters May Predict Cold-Stored Platelet Function at 21 Days | Susan Shea | |
| 397-P | Comparative evaluation of immunochromatographic test (ICT) and chemiluminescence immunoassay (CLIA) for detection of HBV, HCV and HIV among blood donors: The first multi-center study from Bangladesh | Tamanna Afroz | |
| 403-P | Global nucleic acid testing yield in blood donation: A GRADE-informed systematic review and meta-analysis of ID-NAT versus MP-NAT across regions and infection types | Sunil Golia | |
| 405-P | Advancing Blood Safety Through Automated Screening: Comparative Evaluation of HIV and Syphilis Detection Technologies in Pakistan | Maeesa Sajeel | |
| 406-P | An Eight Year Study of Prevalence in Transfusion-transmissible Infections of Malaysia Blood Donors: Pusat Darah Negara Experience | Umar Amali Abd Kadir | |
| 408-P | Re-entry of donors deferred for false-reactive screening tests in Canada: 10 years post-implementation | Sheila OBrien | |
| 409-P | Evaluation of Diagnostic Utility of the Sequential Serological Assay Strategy Compared with NAT for the detection of HIV, HBV, and HCV in the Blood Donor Population | Janet Mankottayil | |
| 415-P | Characteristics of Human Parvovirus B19 Infection in Blood Donors in Lanzhou, China, 2022–2023 | Kangle Wu | |
| 416-P | Implementation of Parvovirus B19 and Hepatitis A Nucleic Acid Testing in Blood Donations: Enhancing Plasma Safety for Fractionation | Grace Agustin | |
| 418-P | Sigma Metric Analysis for Alinity Anti-HCV Assay in National Blood Center, Kuala Lumpur | Muhammad Nor Fazali Bin Fazil | |
| 419-P | Risk-Based Donor Deferral Does Not Increase Infectious Marker Reactivity: Evidence from Colombian Blood Banks (2018–2024) | Michel-Andres Garcia-Otalora | |
| 424-P | Longitudinal Trends, Incidence Rates and Donor Risk Profiles of Seroconversion Among Repeat Blood Donors (2020–2025) | ZANARIAH BINTI KASSIM | |
| 426-P | Residual risk of HIV, HCV and HBV following ID-NAT screening: a 6-year analysis | Elizebeth Mah | |
| 429-P | Impact of Hepatitis B Core Antibody and Hepatitis B Surface Antibody Assay Integration in Nucleic Acid Testing Repeatedly Non-Reactive Screening Algorithms: A Retrospective Study. | Muhammad Taha | |
| 434-P | Validation and benchmarking of a new multivirus NAT assay for blood donor screening | Ralf-Bernhardt Rues | |
| 435-P | We donate: recruitment of new blood and Hematopoietic Stem Cell donors with the "Bimbo dona Papà dona" project | Giuseppa Tancredi | |
| 444-P | Evaluation of an enhanced-sensitivity HBsAg assay for donor screening across three Latin American blood services | Guillermo Andres Orjuela | |
| 447-P | Frequency and trends of Hepatitis B & C, and human immune deficiency virus in blood donors presenting to blood bank of a Tertiary Hospital in Peshawar, Pakistan. | Neelam Ahmad | |
| 450-P | Closing the Gap: A 4-Year Analysis of Hepatitis B Vaccination Pathways and the Need for Integrated Digital Tracking in Regular Blood Donors (2022–2025) | Nuraini Sham | |
| 453-P | Data driven, phased, cost-adaptive blood donor hepatitis B virus (HBV) screening strategy for low-middle income countries (LMICs): Aligning with international standards under funding constraints | Rabia Majeed | |
| 456-P | Can Social Media Convert Engagement into Donation? A Data-Driven Recruitment Model from Kuwait Blood Bank | Eman Monir | |
| 458-P | Epidemiological Trends of Hepatitis C Virus Reactivity Among Blood Donors in Sarawak General Hospital: A Two-Year Surveillance Study | Siew Ling Lu | |
| 464-P | PREVALENCE OF HIV, SYPHILIS, HEPATITIS B AND C IN A REGIONAL BLOOD BANK IN A TERTIARY GOVERNMENT HOSPITAL IN EASTERN VISAYAS | Kristine Joy Abordo Gacutno | |
| 465-P | Evaluation of HIV Screening Protocol: Assessing the Necessity of Segment Sample Testing in Blood Donation Screening | Nur Amirah Binte Rajah | |
| 466-P | Estimating the residual risk of HIV, HBV, and HCV in blood transfusion: a comparison of calculation methods in an upper-middle-income Latin American country | Jean Stanley | |
| 467-P | Residual risk of transfusion-transmitted HIV, HBV and HCV with NAT screening in Colombia, Honduras and Argentina: application of a novel method for estimating incidence in blood donors | Jean Stanley | |
| 469-P | Assessing the cost-effectiveness of screening blood donations for HEV | Igor Rossa-Ramm | |
| 470-P | Assessment of HIV pre-exposure prophylaxis and antiretroviral therapy use in Brazilian blood donors | Renata Buccheri | |
| 473-P | Bacterial Detection in Platelets with and without Platelet Additive Solution: Experience at a Tertiary Care Hospital Blood Centre | Sheenam Thakkar | |
| 475-P | Impact of Diversion Pouch Use on Bacterial Contamination in Blood Components: A Long-Term Retrospective Study | Hari Krishan Dhawan | |
| 476-P | Impact of Bacterial Screening Implementation on Medical Institutions: Analysis of In-Hospital Operations and Supply Chain Challenges | Tadashi Matsushita | |
| 479-P | Evaluating Bacterial Safety Protocol Efficiency: Insights from an Indian Tertiary Care Oncology Centre | Kalpesh Chawan | |
| 481-P | Transfusion-Transmitted Malaria in India: A National Survey of Epidemiology and Associated Blood Donor Screening Practices | Evan Bloch | |
| 482-P | Blood donor Babesia Nucleic Acid Test Surveillance in Nova Scotia, Canada: 2025 | Steven Drews | |
| 483-P | Sentinel surveillance of asymptomatic malaria among blood donors in a malaria endemic region in India : implications for malaria elimination | Girish Singh Kshatriya | |
| 484-P | Malaria parasitemia may be associated with false positive copper sulfate test in blood donor anaemia screening | Foluke Fasola | |
| 485-P | Plasmodium parasitemia in standard platelets concentrates at Yaounde Central Hospital | Hortense Ngegni Pangetna | |
| 490-P | Cost-Effectiveness Analysis on Implementation of Routine Blood Donor Screening of Dengue Virus Among Blood Donors in Kerala- A Economic Modelling Study | Arun M | |
| 495-P | The impact of the 2025 Chikungunya outbreaks in France and Italy on donor management in Switzerland | Sandra Kurth | |
| 496-P | Seroprevalance of human cytomegalovirus among Blood donors in western rajasthan and its clinical implications for immunocompromised Transfusion recepients: A cross-sectional study. | Aman Singh | |
| 497-P | Infectious syphilis in Canadian blood donors | Sheila OBrien | |
| 504-P | Development of Anti-f Antibody in a Multiple Transfused Patient: A Case Report | Nor Basyariah Abdulla | |
| 505-P | The Blueprint vs. The Build: Navigating Genotype-Phenotype Divergence | Lohshana Ganesan | |
| 506-P | Automation in Immunohaematology in resource limited settings is it a safe alternative to conventional tube technique ? | Sudha Ranganathan | |
| 507-P | Procedural factors affecting interlaboratory variability in anti-blood group antibody titration based on proficiency testing data | Jiwoo Lee | |
| 508-P | Anti-Sda: When Pan-reactivity Without Clinical Significance | Gowri Ganason | |
| 514-P | The Deadly Assumption: Why ´Group O´ Isn´t Always Safe | SHI YA CHANG | |
| 515-P | Prevalence of Irregular Antibodies in Blood Donors in Terengganu, Malaysia: A Pilot Study Using Automated Solid-Phase Pooled Cell Screening | Noor Hamizah Mohd Hassan | |
| 516-P | Comparison of ABO group and Rh Phenotype between Sickle Cell Disease Patients and General Donor Population in North Al Sharqyia Region, Oman. | Musleh Al Musalhi | |
| 517-P | Prevalence of various red cell alloantibodies in the Pakistani population- a tertiary care centre´s experience | Komal Masroor | |
| 518-P | Utility of combining enzyme-treated red blood cells with anti-CD38 neutralizing reagents in the indirect antiglobulin test. | Kotono Watanabe | |
| 519-P | Redefining Anti-A1: Clinically Significant ABO Discrepancies in Three A2 Patients | Dhargam Aljebouri | |
| 520-P | Cold Autoanti-IH : Immunohematologic Behavior and Clinical Relevance by Antigen Density | Dhargam Aljebouri | |
| 521-P | A Study Of Clinical Correlation Of Direct Coombs Test In A Referral Blood Bank | Muhammad Faisal | |
| 525-P | An Algorithm with Rule-Out Assistance for Antibody Identification | David Mongin | |
| 526-P | Enhanced automated antibody titration: field evaluation and statistical equivalence analysis versus manual gel methodology | Jessica Payne | |
| 527-P | Phenotypic Distribution of ABO, Rh and Kell-1 Blood Group Antigens among 3,090 Iraqi Blood Donors: Implications for Transfusion Practice | Yaqoob Almusawi | |
| 535-P | Specificity and Prevalence of Red Blood Cell Alloantibodies among Patients in Latvia | Solvita &268;er&326;avska | |
| 538-P | Multi-center clinical assessment of a neutral gel matrix card for ABO reverse grouping: performance and matrix equivalence | Jessica Payne | |
| 542-P | The rare that matters: managing Bombay blood group in obstetric emergency | arif azhar | |
| 543-P | Appraisal of blood grouping difficulties, antibody specification and titration, among the patients with Cold Agglutinin Disease in a tertiary care hospital, Bangladesh | Sonia Shormin Miah | |
| 544-P | Anti-Jkb–Mediated Delayed Serologic Transfusion Reaction in End-Stage Renal Failure | Mohamad Afif Abdul Ramlan | |
| 545-P | Analysis of the dynamics of alloimmunization to red blood cell antigens from 2008 to 2025 | Irina Krobinets | |
| 546-P | Serological Challenges in Blood Group Typing: A Rare AB3 Subgroup Phenotype | Wan Mohd Hafizuddin | |
| 549-P | Delayed Serological Transfusion Reaction secondary to Anti Jka in a pregnant patient with no previous sensitisation | MUHAMAD ZAHARI | |
| 550-P | Prevalence of red blood cell antibodies among patients in Peninsular Malaysia: a retrospective observational study at four major referral tertiary care hospitals | Pei Pei Tan | |
| 556-P | Pre-transfusion testing challenges caused by a clinically significant anti-P1 antibody: a case report | Diah Puspita Rini | |
| 560-P | A Rare Case of Parabombay B in a Young Boy | Jannah Mat Noh | |
| 565-P | Predicting Antigen Negativity Using SPRCA Crossmatch Strength: A Conservative Strategy for Complex Alloimmunized Patients- A Resource-Efficient Strategy | Vadad Khaliq | |
| 566-P | Screening for the kidd null phenotype using the direct urea lysis test: a cost-effective strategy for large-scale screening in a blood centre of a tertiary care hospital | Sindhu Manikandan Nair Sarasamma | |
| 571-P | Prevalence of Anti Mia antibody among patients admitted at Hospital Sultan Ismail, Johor Bahru | THAENUJAH NAIR RAMACHANDRAN | |
| 572-P | A Rare Case of Persistently Negative Antibody Screening in Warm Autoimmune Hemolytic Anemia: Lessons for Transfusion Practice | Syahirah Mohamed Yusoff | |
| 573-P | Rh Phenotype Distribution Among Blood Donors in a Multi-Ethnic Malaysian Population: Experience from Taiping Hospital, Perak, Malaysia | Nurulraihan Mohamed Zawawi | |
| 576-P | Evaluation of Automated Solid-Phase Red Cell Adherence Technology for Red Cell Antibody Identification: A Pilot Comparative Study | Noor Hamizah Mohd Hassan | |
| 577-P | Evaluation of the Inclusion of Di(a+) Red Cells in Antibody Screening Panels for Thalassaemia Patients in Malaysia | Mohd Muhaimin | |
| 579-P | Analytical performance and comparative evaluation of papain-treated 0.8% reagent red blood cells for antibody identification using gel technology | Jessica Payne | |
| 583-P | Prevalence Of Red Blood Cell Antibodies Among Patients In Hospital Taiping | Farah Nadia Binti Osman | |
| 584-P | Anti-Idiotypic Anti-Daratumumab to Mitigate the Interference of Daratumumab in Pre-Transfusion Testing | Molly Rutherford | |
| 586-P | ABO and RhD blood grouping: A comparative study of tile, gel card, and solid-phase methods | Lee Woan Chyi | |
| 589-P | Effect of anti-CD38 monoclonal antibody titer on the neutralizing efficacy of soluble CD38 | Masaya Yoshida | |
| 590-P | When RhD-Negative Blood Is Unavailable: Post-Exposure High-Dose RhIg Following Emergency RhD-Positive Transfusion When RhD-Negative Blood Is Unavailable: Post-Exposure High-Dose RhIg Following Emergency RhD-Positive Transfusion When RhD Negative Blood Is Unavailable: Post-Exposure High-Dose RhIg Following Emergency RhD Positive Transfusion | NUR FAZIRA EKMA MOHID | |
| 591-P | Determination of Anti-A and Anti-B Titers in blood donors using automation in Northern Taiwan | Shu-Hui Feng | |
| 594-P | Prevalence and Profile of Maternal Red Cell Antibodies: A Retrospective Study at the National Blood Centre Malaysia | Rubika Umadas | |
| 595-P | Impact of Daratumumab Interferences on Laboratory Resources and Workflow: Evaluation of New Reagent | Selvamani Anbu Mani | |
| 596-P | CROSS-MATCH POSITIVE BLOOD TRANSFUSION-CASE REPORT | Tatjana Makarovska Bojadzieva | |
| 597-P | Antenatal Immunohaematology - preparing to save two lives | Sudha Ranganathan | |
| 598-P | RhD serotyping discrepancies: need to define "Serological partial D" | Dheeraj Khetan | |
| 600-P | Pan-reactive but Harmless? The Curious Case of Anti-Sd? | Yasshni Ponnu Swomy | |
| 604-P | Does Every Positive DAT Need an Elution? Clinically Significant Eluate in DAT-Positive Samples: A Retrospective Study | Aisyah zairul | |
| 605-P | Reagent Red Blood Cell Production: The Crucial Partnership Between Donor Center and Manufacturers | Michelle Mullens | |
| 606-P | This or That? A Case of Discordant Red Blood Cell Typing in the Kidd System and Its Clinical Implications | Raihan Marini Ramli | |
| 607-P | Identifying RhD variants in local patient populations using serological testing platforms: A potential blind spot for blood transfusion services in India | SUVRO SANKHA DATTA | |
| 608-P | The forgotten XG blood group system: a case of anti-Xga alloimmunisation | Mohd Redzuan Abdullah | |
| 611-P | Recovery and phenotyping of autologous red blood cells in recently transfused patients :A feasibility study | V AISHWARYA | |
| 612-P | ABO and RhD Blood Group Mapping Among Patients in a Tertiary Hospital in the Klang Valley: A Six-Year Experience | Nusaibah Wan Zulkipli | |
| 613-P | When O Isn´t O: Identification of the Bombay Blood Group in an Iban Maternity Patient at Hospital Sibu, Sarawak | Wei Wei Loh | |
| 614-P | Clinical Significance of Maternal Anti-Le b with Wide Thermal Amplitude in Neonatal Cardiac Surgery: A Case Report | Nur Zafirah Mohd Kamaludin | |
| 615-P | The Silent Antigen: Acquired Tn Polyagglutination in a Patient with Myelodysplastic Syndrome | Nurul Hidayah Zahari | |
| 617-P | Rh and Kidd Blood Group Phenotypes: Insights from Blood Donors in Terengganu | Roslina Remli | |
| 618-P | Auto Anti-B - a rare occurrence found in a Patient with CD5-/CD10- Small B-cell Lymphoproliferative Disorder. A Case Report from a Local Tertiary Hospital. | Ting Yi Tan | |
| 619-P | THE PREVALENCE OF SUBGROUP A AND B AMONG BLOOD DONORS IN NATIONAL BLOOD CENTER (NBC) | WAN ROSINAWATI WAN IBRAHIM | |
| 622-P | Prevalence of red cell alloantibodies among patients at a tertiary care hospital in Alor Setar, Kedah, Malaysia | Lee Woan Chyi | |
| 625-P | Investigation of a commercial monoclonal anti-D typing reagent as a potential quality control reagent in the monocyte monolayer assay | John-Paul Tung | |
| 626-P | Identification of Anti Er5 in Two Japanese Patients with the ER:-5 Phenotype | Sayaka Okajima | |
| 627-P | Enzyme-Assisted Identification of Multiple Red Cell Alloantibodies Under Resource Constraints | Dilini Ranasinghe | |
| 628-P | Implementing International Standard Compatibility Testing in a Healthcare-Funded LMIC Hospital - Strengthening Transfusion Safety | Fatima Meraj | |
| 629-P | Resolving an ABO Discrepancy in a First-Time Donor with Rare Ax/Aw Subgroup | Sharifah Sakinah Syed Abdul Rahman | |
| 634-P | A serologic challenge: anti-D reactivity in a RhD positive patient | Nurakmal Aqilah Isro | |
| 635-P | Red blood cell alloimmunisation among antenatal patients at Hospital Al-Sultan Abdullah Universiti Teknologi MARA | NUR ROSLAN | |
| 636-P | From Routine to Evidence-Based Practice: Optimizing Elution Testing for Smarter, Clinically Relevant Diagnostics | SHI YA CHANG | |
| 637-P | Optimizing direct and indirect antiglobulin testing through indication-based stewardship in a tertiary care hospital | Mahizhan Rajendran | |
| 638-P | Not All B Is B: Detection of Acquired B Antigen in a Group A Patient with Colorectal Carcinoma | Norsuzilawati Abdullah | |
| 639-P | An A3subgroup presenting as ABOdiscrepancy in a newly diagnosed leukemia patient a diagnostic challenge | Subash Sadanandan | |
| 640-P | Anti-Chido/Rodgers: Resolving Serologic Ambiguity in the Blood Bank | Syuhada Zulkifly Apandi | |
| 645-P | A case of complex antibody identification: integration between digital solution and laboratory evaluation | Rosana Pacciolla | |
| 646-P | Serologic interference after intravenous immunoglobulin (IVIG) infusion in a paediatric patient requiring granulocyte transfusion in a paediatric oncology patient | Mohamad Asyrab Sapie | |
| 648-P | Unmasking Tn polyagglutination in a paediatric patient with sepsis : A case report | Ashwini Rajagopal | |
| 652-P | A two-year Evaluation of "A2 and A2B Blood Groups with A1 Antibodies" Among Turkish Red Crescent (TRC) Blood Donors Covering The Years 2023-2024; From The Perspective of A Blood Bank IH Laboratory. | Ozgur Rustu Guner | |
| 653-P | Analytical performance and repeatability of a neutral gel card for reverse ABO grouping across manual and automated platforms | Jessica Payne | |
| 654-P | Analytical performance and Rh variant detection using gel-based Rh phenotyping cards across automated and manual platforms | Jessica Payne | |
| 655-P | Multisite precision and clinical method comparison of 3% reagent red blood cells for reverse ABO grouping using the tube method | Jessica Payne | |
| 657-P | Serological pre-testing for efficacy and safety of complement inhibitor sutimlimab in patients with various autoimmune haemolytic anaemias | Thilo Bartolmäs | |
| 658-P | Large-scale multi-center clinical evaluation of a column agglutination technology for Rh phenotype (C, c, E, e) determination | Jessica Payne | |
| 659-P | Case Report: Putative Compound Anti-RH1/MNS3 | Morgan Gueuning | |
| 661-P | Alloimmunization in Transfusion-Dependent Thalassemia patients attending a tertiary care hospital | Tanzila Tabib Chowdhury | |
| 663-P | Challenges in Detecting Anti-CD36 as a red blood cell Antibody within the Japanese Screening System | Toru Miyazaki | |
| 665-P | Molecular Confirmation of Asian DEL in an Offspring of RhD-Positive Parents | Asriza Abdul Malik | |
| 667-P | A "Silent" Antigen Speaks: Anti-D Alloimmunisation from Asian-type DEL Red Cell Transfusion | Norsuzilawati Abdullah | |
| 669-P | Geographic boundary for the Asian-type DEL in South Asia | willy (bill) albert flegel | |
| 670-P | "THE ROLE OF ABO BLOOD GROUP SYSTEM IN THE OCCURRENCE OF VENOUS THROMBOEMBOLISM" | Elena Ristovska | |
| 674-P | Identification of three novel LAN null alleles | Louise Tilley | |
| 676-P | From donor genotype to patient care: fifteen years of donor genotyping to build a rare blood inventory and enable precision transfusion support | Christine Henny | |
| 677-P | Extended genotyping of blood donors by next generation sequencing | Daniel Fürst | |
| 678-P | Loss of heterozygosity analysis for deciphering two cases with challenging RHCE serology | Morgan Gueuning | |
| 679-P | Evaluation of a validated array platform for blood group antigen and allele prediction using routine and special samples pre-genotyped by MALDI-TOF mass spectrometry | Stefan Meyer | |
| 681-P | Study on the serological characteristics and molecular biological analysis of samples mistyped as O phenotype | Yuwan Dai | |
| 682-P | Real-World Application of RHD Genotyping for Asian-Type DEL Management in RhD-Negative Antenatal Women: The Terengganu, Malaysia Experience | Mohamad Afif Abdul Ramlan | |
| 683-P | Identification and Functional Characterization of a Rare ABO Allele Carrying the c.280A>T Variant Associated with a Weak A Phenotype | Qi Liu | |
| 687-P | Rh DEL Phenotype in Pregnancy: A Case Highlighting the Importance of Early Detection by Molecular RhD Genotyping | Yi Ling Ang | |
| 688-P | Identification of three new JR null alleles by serological and genetic analyses | Vanja Karamatic Crew | |
| 690-P | Two new FUT1 alleles resulting in H-deficient red cell phenotypes | Louise Tilley | |
| 692-P | Serological and molecular investigation of a case of the In(Lu) phenotype with a novel genetic background, discovered incidentally during an antibody investigation | Vanja Karamatic Crew | |
| 693-P | A novel p.Met52Arg substitution in ICAM-4 causes a serological LW null phenotype | Nicole Thornton | |
| 696-P | Resolution of Red Cell Phenotype–Genotype Discrepancies in Repeat Blood Donors: Molecular Characterisation of RHCE and GYPB Variants in Singapore | Weng Yik NG | |
| 697-P | Bioinformatics Analysis of RHD1227A DEL Asian-Type Protein: Sequence, Structure, and Functional Characteristics | Dandan Han | |
| 698-P | Discrepant serologic RhC typing using different methods and the underlying molecular genetic background | Elke Weinig | |
| 700-P | Detection of D Variants in Kuwait by Molecular Genotyping Using Fluorescence Based Real Time PCR | Amna Al-Shemmari | |
| 708-P | Performance Evaluation of a Red Cell Sequencing Kit for Accurate Blood Group Genotyping | ROZI HANISA MUSA | |
| 712-P | Evaluating the artificial intelligence tool, AlphaGenome, in predicting the regulatory potential of non-coding variants in blood group genes | Martin L Olsson | |
| 714-P | Diagnostic Challenges in RHD Genotyping: A Family Study of a Suspected Rare RHD Null Allele | Nur Afiqah Nordin | |
| 715-P | Blood group profile of Japanese population: Analysis based on whole genome database | Masamichi Mikame | |
| 717-P | The First Case Reported of Suspected Anti-Do? with Multiple Alloantibodies in Malaysia | Alia Mohd Nasir | |
| 722-P | Screening for population-specific blood group gene variants in Blood Donors by high-throughput ddPCR | Eva Maria Matzhold | |
| 723-P | First comprehensive investigation of the molecular polymorphism of RHCE in Thailand: getting fundamental data to prevent the risk of alloimmunization in patients with thalassemia | Pornlada Nuchnoi | |
| 726-P | Design and Implementation of A GRCh38-harmonised Kidd (SLC14A1) Variant Knowledgebase: A Framework for Conservative Haplotype Inference and CRISPR-based Validation | Jie XU | |
| 733-P | Rare anti-hrs alloimmunization in a DAR-ceAR pregnant woman: the vital synergy between hospital screening and reference molecular diagnostics | Barbara Baluce | |
| 734-P | Accurate Prediction of U and Uvar antigen status is Critical | Sabine SCHOLZ | |
| 735-P | Interindividual differences in H blood group antigen levels on group O red blood cells - a striking and previously unrecognized phenomenon | Emir Ademovski | |
| 736-P | The Speckled D: Solving a Rh Blood Group Mystery for Safer Transfusions | Shashminie Patma Jothy | |
| 740-P | Comparative analysis of MAIPA and PakLx for detection of platelet-specific alloantibodies: implications of assay limitations | Klara Asplund Högelin | |
| 746-P | Laboratory investigation and crossmatch of platelet refractoriness due to strong HLA antibody and HP 2b. A case report | NANG IBRAHIM | |
| 749-P | Prevalence of Human Leucocyte Antigen (HLA) Antibodies in Platelet Transfusion Refractoriness: Experience from National Blood Centre, Malaysia | Puteri Sollehah Azlan | |
| 750-P | Neonatal Alloimmune Thrombocytopenia Caused by Maternal Anti-HLA Class 1 Antibodies : A Family Case Report with Serological and HLA Typing Correlation | NORLIZA IBRAHIM | |
| 752-P | Broad Platelet & HLA Antibody Reactivity Detected By MAIPA In Recurrent Infantile Immune Thrombocytopenia | Noor Sheereen Adzaludin | |
| 753-P | Dominance of anti-HLA over anti-HPA antibodies in platelet immune-mediated disorders: A six-year national referral experience | NURUL MUNIRA YAHYA | |
| 756-P | Optimising HLA-Selected Platelet Provision in Wales Through Targeted Recruitment from the Welsh Bone Marrow Donor Registry | Kalinga Perera | |
| 758-P | DISTRIBUTION OF HUMAN PLATELET ANTIGENS-1 TO -6, -9 AND -15 IN HONG KONG BLOOD DONOR POPULATION | Emily Ho | |
| 761-P | Investigating the Association Between anti-Human Leukocyte Antigen (HLA) Antibodies and Fetal and Neonatal Alloimmune Thrombocytopenia | Shoma Baidya | |
| 766-P | Fetal and neonatal alloimmune thrombocytopenia - A case report | Angelina Cvijovi&263;-Ranitovi&263; | |
| 767-P | Primary Anti-D Alloimmunization in a Nulliparous Woman: From Recurrent Hydrops Fetalis to Preventive Embryo Selection | Dhargam Aljebouri | |
| 770-P | Triple Rh Alloimmunisation in Pregnancy: A Case of Combined Anti-D, Anti-C, and Anti-E Resulting in Hemolytic Disease of the Fetus and Newborn (HDFN) | Syahirah Mohamed Yusoff | |
| 772-P | Clinically Significant Anti-M in Pregnancy: The Important Role of Transfusion Medicine in Multidisciplinary Care | Muhammad Noor Haziq Ibrahim | |
| 774-P | Frequency, Risk factors and Outcome of Hemolytic Disease of Newborns due to RhD incompatibility- A single centre study | Maria Owais | |
| 775-P | Maternal Breast Milk IgG Mediated Delayed Hemolysis in an Infant: A Case Report and Immunological Insight | Pallavi Singh | |
| 785-P | When O Is Not O: Unmasking Bombay and Para-Bombay Blood Groups in Repeat and Lapsed Donors A Case Series Highlighting ABO Discrepancies and Rare Donor Detection | Ainul Nadiah Binti Salam | |
| 786-P | Rare Blood Group Management in Obstetrics: Case Report of MAM-Negative Patient | Ambika Nakulan | |
| 789-P | Two Bombay Cases; Serological And Molecular Analysis Approach Of The Turkish Red Crescent Immunohematology Laboratory | Ozgur Rustu Guner | |
| 791-P | RBC transfusion in Neonates diagnosed Necrotizing Enterocolitis (post diagnosis) at Hospital Sultanah Bahiyah Alor Setar, Malaysia | Siti Nur Athirah Ahmad | |
| 793-P | Pre-Cord: From Delivery Room to Blood Bank — Feasibility of Supplying Extremely Preterm Neonates With Cord Blood Red Blood Cells | Jip van Daelen | |
| 794-P | Intrauterine Transfusion in a Foetus with Homozygous Southeast Asian Ovalocytosis: A Case Report | Khui Yie Chew | |
| 795-P | A comparative analysis between Retrograde Autologous Blood Priming (RAP) versus Allogenic Blood Priming in Cardio-Pulmonary Bypass circuits during Pediatric Cardiac Surgery | DEBASISH GUPTA | |
| 796-P | Is there a need to consider addition of platelets during reconstitution of blood unit for Exchange Transfusion based on baseline platelet counts in infants? | Aparupa SenGupta | |
| 798-P | When Rare Blood Meets Limited Resources: Transfusion Challenges in a JK-Null HbE ß-Thalassaemia Patient | Nur Syafika Atia Muktar | |
| 799-P | Evaluation of Packed Red Blood Cell Utilization and Appropriateness in a Pediatric Tertiary Care Cohort: A Five-Year Retrospective Audit | Amit Ajay Pawar | |
| 801-P | Effect of transfusion of packed red blood cells of different storage duration in preterm neonates: A Prospective Observational Study | Sandhya Sadhanand | |
| 802-P | A lack of scientific evidence and consensus leads to significant variation in massive transfusion protocols used to treat massive hemorrhage in children and neonates across Dutch university hospitals | Elise Huisman | |
| 805-P | A Rare Presentation of Vitamin B12 Deficiency: Severe Macrocytic Anemia, Thrombocytopenia, and Intramedullary Hemolysis | Vanessa Oliveira | |
| 806-P | A Case Report : Glanzmann Thrombaesthenia in Obstetrics Patient in Penang District Hospital, Malaysia : Transfusion Management | Faezah Fauzi | |
| 809-P | Comparing the efficacy of low volume vs standard volume plasma exchange in patients with acute liver failure - A randomized controlled trial | Anu Ragavan | |
| 812-P | Standard-volume versus high-volume therapeutic plasma exchange in acute liver failure: comparable efficacy with implications for transfusion practice | Pragati Naik | |
| 815-P | APPLICATION OF PLASMA EXCHANGE IN THE TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA - A RETROSPECTIVE SINGLE CENTER STUDY | Bin Zhang | |
| 817-P | Adverse events in therapeutic apheresis: Insights from a tertiary care center in eastern India | Satya Prakash | |
| 819-P | Therapeutic plasma exchange as rescue therapy in life-threatening veno-occlusive disease following hematopoietic stem cell transplantation. A case report. | Pragati Naik | |
| 820-P | Comprehensive Age-based Assessment of Thrombotic Thrombocytopenic Purpura: Clinical and Laboratory Features, Treatment Patterns, and Outcomes | Nour AlMozain | |
| 821-P | Red Cell Exchange as a Rescue Therapy in Severe Propanil Poisoning: A Sri Lankan Case Series | Gunasekara Disanayakage Dilani Nalika Kumarasinghe | |
| 822-P | Therapeutic plasma exchange for leptospirosis associated severe pulmonary haemorrhage syndrome with multiorgan failure, a two-case series | Weerappulige Roshni Tharaka Priyanjani | |
| 823-P | Capecitabine-Associated Thrombotic Microangiopathy with Evidence of Terminal Complement Activation in Metastatic Breast Cancer | Nour AlMozain | |
| 824-P | Results of GVHD treatment with various modifications of extracorporeal photopheresis | Irina Kumukova | |
| 825-P | Ten-Year Prospective Experience of Therapeutic Plasma Exchange in Autoimmune Neurological and Gastroenterological Diseases from a Tertiary Care Centre in South India | MAHESH KUMAR KANDUKURI | |
| 826-P | Safety and Efficacy of Apheresis in Children: A Comparative Study of Therapeutic Leukoreduction in Severe Pertussis Infants versus PBMC Collection in Healthy Pediatric Donors | Yixin Gao | |
| 828-P | The Use of Selective Plasma Adsorption of Isohemagglutinins in Managing Partial Red Cell Aplasia Post-Allo-HSCT | Alexandra Shcherbakova | |
| 829-P | Early High-Volume Selective Immunoglobulin Removal By Cascade Plasmapheresis for Antibody-Mediated Rejection: A Safe and Effective Approach for Resource-Limited Settings | DIVYA SETYA | |
| 835-P | Severe Allergic Reaction During Pre-Transplant Plasmapheresis in ABO-Incompatible Renal Transplantation | Maryam Jameelah Aizuddin | |
| 838-P | Analysis of Electronic Positive Patient Identification (ePPID) Mismatch Alerts at a Large Academic Hospital (2017–2024) | Widad Abdulwahab | |
| 839-P | Transfusion Outcomes in Platelet Transfusion Refractoriness Patients Receiving Crossmatch-compatible Platelets: Study in Malaysian Hospitals | Muhammad Noor Haziq Ibrahim | |
| 842-P | Transfusion Burden in Autoimmune Haemolytic Anaemia: Association with Clinical Severity and Direct Antiglobulin Test Phenotype in a Malaysian Tertiary Hospital | Galtani Noor Shafika | |
| 844-P | Successful Resolution of Neutropenic Sepsis in Pediatric Oncology via Granulocyte Transfusion: A Case Report | TTARCINI ENGATRAMANA | |
| 846-P | Beyond Antiretroviral Therapy: Plasma as a Lifesaving Modality in HIV-Associated Thrombotic Thrombocytopenic Purpura | Afif Alam Faizli | |
| 849-P | The association of blood Transfusion and medical resources utilization in Palliative Care for Sepsis | Ju-Huei Chien | |
| 854-P | Utilisation Pattern of Apheresis Platelets in a Secondary Hospital: A Five-Year Experience from Taiping Hospital, Malaysia | Nurulraihan Mohamed Zawawi | |
| 855-P | Analysis of RBC transfusions in hospitalized patients with iron deficiency anemia: 3-year trends and contemporary nationally representative estimates from the USA | Anvi Agarwal | |
| 856-P | Development and Evaluation of an Innovative Screening Tool for Heavy Menstrual Bleeding in Female Blood and Plasma Donors: A Validation Study | Su Someh | |
| 857-P | Research on Replacement of plasma components in Chronic Liver Cell Disease (CLCD) patients at Colombo North Teaching Hospital, Sri Lanka | M Nadeeshani Fernando | |
| 858-P | Survey on characteristics of blood product transfusion in patients receiving hematopoietic stem cell transplantation at Bach Mai Hospital (2021–2025) | Minh Tam Vu | |
| 861-P | Knowledge and Practices of Blood Transfusion and Patient Blood Management (PBM) Among Medical Officers in Hospital Rembau | MUGUNTHAN M. SATHIVAL | |
| 862-P | Multidisciplinary consulting meeting for complex transfusion in sickle cell disease: a 4-year review in France | France Pirenne | |
| 863-P | Clinical agreement and prognostic implications of ADAMTS13 activity in thrombotic microangiopathy: automated chemiluminescent immunoassay versus ELISA | Susung Kim | |
| 864-P | Transfusion Evidence RoundUps and the Talking Transfusion Podcast: a collaboration to enhance outcomes for patients and donors by increasing the dissemination of the transfusion medicine evidence base | Susan Brunskill | |
| 865-P | ANALYSING THE RATIONALE BEHIND PLATELET TRANSFUSION SUPPORT IN PATIENTS WITH SEVERE AND NON-SEVERE DENGUE | Raj Bharath | |
| 867-P | Malignancies diagnosed in blood donors: three case histories and the implications for transfusion safety | Kalinga Perera | |
| 868-P | Efficiency and Safety Gains from Bedside Electronic Transfusion Checks in four hospitals in England | Florence Oyekan | |
| 869-P | Quantifying the Long-Term Quality-of-Life Impact of ABO-Incompatible Transfusion Events Using SHOT Data and Clinical Evidence | Josephine McCullagh | |
| 870-P | Prolonged continuous platelet infusion in refractory hemato-oncological patients with bleeding or high hemorrhagic risk: a single-centre experience | Andrei Kolesov | |
| 871-P | Staff satisfaction with the use of Bedside Electronic Transfusion Checks at three hospitals in London | Florence Oyekan | |
| 872-P | Clinical Benefits of Bedside Electronic Transfusion Checks – A before and after comparative study | Josephine McCullagh | |
| 874-P | Bridging the Gap in Patient Blood Management: A Mixed-Methods Evaluation of Clinician Knowledge and Transfusion Decision-Making | Pallavi Singh | |
| 875-P | A Comparative Study of Irradiated versus Non-irradiated Platelet Transfusion in Liver Transplantation: No Adverse Impact on Perioperative Recovery and Graft Function | Li He | |
| 877-P | Appropriateness of Prophylactic Platelet Transfusion Requests at National Hospital of Sri Lanka | Gunasekara Disanayakage Dilani Nalika Kumarasinghe | |
| 879-P | Comparative Effects of Buffy Coat–Depleted and Pre-storage Inline Leukoreduced PRBC Transfusion on Outcomes in Critically Ill Surgical Patients. | DEEREJ P | |
| 882-P | Transfusion-Associated Hyperkalemia Following Transfusion of Irradiated Red Blood Cells in Massive Transfusion: Two Case Reports and Quality Audit Analysis | Ghadah Alyami | |
| 887-P | Effectiveness and Operational Performance of a Massive Transfusion Protocol: A Two-Year Retrospective Analysis | Muhamad Arif Mohd Zahari | |
| 888-P | Safety and Transfusion Outcomes Following Implementation of Thawed Group A Plasma in the Operating Theatre: A One-Year Single-Centre Experience | Muhammad Khairil Azizi Bin Che Omar | |
| 889-P | Utilisation of Targeted Haemostatic Therapy in the Management of Postpartum Haemorrhage in Chronic Refractory Immune Thrombocytopenic Purpura: A Case Study | Norkhazarina Binti Omar | |
| 890-P | Seconds from Silence: The ROTEM Revolution in Maternal Rescue | Yasshni Ponnu Swomy | |
| 891-P | Low FXIII activity levels in patients with vascular anomalies, not in patients with trauma-induced coagulopathy | Takayuki Nakayama | |
| 892-P | Clinical Utilisation of Fibrinogen Concentrate in Severely Bleeding Non-Cardiac Patients: A Single-Centre Observational Study | Omar Norkhazarina | |
| 894-P | ROTEM Profiles in Patients Requiring Massive Transfusion Protocol: A Tertiary Hospital Experience | Muhammad Noor Haziq Ibrahim | |
| 895-P | Massive transfusion patterns and group O RhD-negative red blood cell inventory in the Capital Region of Denmark, 2007–2022 | Martin Vigstedt | |
| 899-P | Optimising massive transfusion protocol response with on-site thawed plasma: A 30-month pre- and post-implementation experience from a level I trauma centre | Nabila Ramlan | |
| 900-P | Review of Massive Haemorrhage Protocol Activations at a Major Trauma Centre | David Roxby | |
| 901-P | Adherence to ROTEM-Guided Transfusion During Massive Transfusion Activation: A Retrospective Analysis from a Tertiary Centre in South Australia | David Roxby | |
| 902-P | The Silent Struggle: Overcoming Heparin Resistance and ECMO Support in CABG | NOOR BINTI ASHAMUDDIN | |
| 903-P | From Crisis to Control: Implementing Massive Transfusion Protocol (MTP) in Amniotic Fluid Embolism (AFE) with disseminated intravascular coagulation (DIVC)- Prince Court Medical Centre Experience | Choong Li Hwa | |
| 904-P | Stable on Average, Delayed in Reality: Identifying Hidden After Office Hours Vulnerability Before ROTEM-Guided Massive Transfusion | ZANARIAH BINTI KASSIM | |
| 905-P | Experience with a Massive Transfusion Protocol in a Tertiary Hospital in East Malaysia: A 3-Year Retrospective Study | Zarifah Adilah Adilah Abdul Rahman | |
| 906-P | Value of Baseline Prothrombin Time (PT%) in Predicting Clinical Outcomes and Transfusion Burden in VA-ECMO Patients | Thanh Nguyen Chi | |
| 911-P | Probable TRALI Type II in a Pediatric Patient with Biliary Atresia and Asthma: A Case Report | SHARMILA MANIAN | |
| 912-P | TRALI Type I Following Red Cell Transfusion from a Donor with Multi-Specific Anti-HLA Antibodies: A Case Report | Nithiyaa Bala | |
| 914-P | Transfusion-Associated Circulatory Overload (TACO) in Cardiac Surgery: An Underrecognized Clinical Challenge | Almedina Spiljak | |
| 915-P | When Blood Types Clashes: A Hemolytic Crisis Unfolds | Yasshni Ponnu Swomy | |
| 917-P | A case of donor HLA antibody–mediated transfusion-related acute lung injury (TRALI) type 1: implications for transfusion safety awareness | Ravines Selvaraju | |
| 918-P | A rare case of a healthy young woman, developing hyperhaemolysis after erythrocyte transfusion. | Kathrine Johnsen | |
| 919-P | TRANSFUSION RELATED ACUTE LUNG INJURY : UNVEILING A PUBLIC EPITOPE? | SUDARCINI ARUMUGAM | |
| 921-P | More Than Just a Transfusion Reaction: A Fatal Case of TRALI | Muhammad Khairil Azizi Bin Che Omar | |
| 923-P | Transfusion Reactions Associated with Hematopoietic Stem Cell Infusions from Female Donors: A Retrospective Pediatric Study | FATMA BURCU BELEN APAK | |
| 924-P | Anti-human neutrophil antigen antibody mediates post-transfusion severe neutropenia | Sheng-Hsuan Chien | |
| 925-P | Impact of a targeted pre-transfusion checklist on the incidence of TACO: A six-year quality improvement study (2020–2025) | NUR FAZIRA EKMA MOHID | |
| 926-P | Multidimensional exploratory data analysis of pulmonary transfusion reactions reported to SHOT | tom Latham | |
| 927-P | AN AUDIT ON TRANSFUSION REACTION CASES IN HOSPITAL SULTANAH BAHIYAH FOR YEAR 2024 - 2025 | Mohamd Syazwan Ahmad Zubaidi | |
| 928-P | The Incidence of anti-IgA in patients with absolute deficiency or very low levels of Immunoglobulin A | Margaret Keller | |
| 932-P | Leukocyte Antibody Screening in Platelet Apheresis Donors: The Taiwan Experience | Ling-I Hsu | |
| 935-P | AN AUDIT OF OVERNIGHT BLOOD TRANSFUSION: ASSESSING PATIENT SAFETY AND POTENTIAL RISKS | Syahirah Mohamed Yusoff | |
| 938-P | PROFILE OF LEAST INCOMPATIBLE TRANSFUSIONS IN ALLOIMMUNIZED PATIENTS: A RETROSPECTIVE STUDY IN INDONESIA | Betty Agustina Tambunan | |
| 939-P | An Audit on Near Misses and Incorrect Blood Component Transfused (IBCT) in a Lead Cluster Hospital, Northern Malaysia | Nor Basyariah Abdulla | |
| 940-P | Epidemiological Profile of Transfusion Reactions Since 2007 : Hemovigilance Data from La Rabta University Hospital, Tunis | Mayar Srairi | |
| 942-P | Near-Miss Events in Blood Transfusion at Taiping Hospital: A Three-Year Haemovigilance Review (2023–2025) | Nurulraihan Mohamed Zawawi | |
| 944-P | Haemovigilance system maturity: A structured national review from Malaysia | Farahin Amat Tamiyes | |
| 945-P | Timeliness of blood component utilization after issue at Bach Mai Hospital | Minh Tam Vu | |
| 946-P | Assessment of nurses´ knowledge in blood transfusion practices: gaps and training implications | Noor Elahi | |
| 948-P | Incidence of Transfusion Reactions by Blood Component: A Four-Year Haemovigilance Study at Hospital Al-Sultan Abdullah (HASA) | Wan Asmuni Wan Mohd Saman | |
| 949-P | Human Factors Contributing to Transfusion Errors: Lessons from Taiping Hospital, Malaysia, a Hospital Haemovigilance System | Nurulraihan Mohamed Zawawi | |
| 951-P | Post-transfusion alloimmunization in allogeneic and autologous hematopoietic stem cell transplant recipients: incidence estimates and platelet-imputed reports | Aline MIRRIONE-SAVIN | |
| 952-P | The rising tide of Transfusion-Associated Circulatory Overload: A 5-Year national haemovigilance analysis of component-specific risk (2020-2024) | Nur Nadira Abd Rahim | |
| 953-P | Same name, same ward, wrong patient; a review of ABO-incompatible red cell transfusions due to collection errors | Nicola Swarbrick | |
| 954-P | Near miss trends as an indicator of transfusion safety improvement over a decade | Theanmulllai Palanisamy | |
| 955-P | Distinct profile of serious adverse events in haematopoietic stem cell transplant recipients: a 10-year national haemovigilance analysis | Aline MIRRIONE-SAVIN | |
| 957-P | When the Transfusion Chain Breaks: Insights of Transfusion Errors at a Tertiary Hospital in Malaysia | NOOR FAKHIRAH MOHD LAZIM | |
| 958-P | Reproducible Immediate Haemodynamic Instability Following Minimal Red Cell Exposure: An Uncommon Presentation | SEETHALA DEVI MARATHAMUTHU | |
| 959-P | National Survey on the Current State of Strengthening Hemovigilance Systems in Medical Facilities in Japan | Junko Nishioka | |
| 961-P | Active hemovigilance in concurrent platelet-plasma apheresis: Insights into donor safety and procedure efficiency | Manuel Gutiérrez de Ravé | |
| 963-P | Postoperative Hematoma and Transfusion Challenges in Factor V Deficiency: A Case Report | Engku Hamidah Muhammad Azmi | |
| 964-P | From Unsafe Practice to Patient Harm: A Preventable Non-Immune Haemolytic Transfusion Reaction | Naqib Wazir | |
| 966-P | Impact of Universal Leukoreduction on Transfusion Reaction Trends: Eight-Year Data from the Taiwan Haemovigilance Network | Huang Jingchun | |
| 973-P | Off Label Use of Four- Factor Prothrombin Complex Concentrate (4F- PCC): A Retrospective Single Centre Study | Noraini Mohamad Zain | |
| 979-P | Rare Kell (KK) phenotype in pregnancy: a case report of an Algerian-descendant woman in Malaysia | Abdul Hadi Che Zainol Ariff | |
| 980-P | The Clinical Value of HLA-Matched, ABO Major-Compatible Platelet Transfusion | yulin Jiang | |
| 981-P | Audit of Erythrocyte Concentrate Utilization and Transfusion Indications at Clinical Hospital Shtip: Toward Implementation of Patient Blood Management | MERI SHOROVA | |
| 984-P | Apixaban-associated post-mastectomy haematoma in male breast cancer: implications for transfusion practice | Premawathi Govindasamy | |
| 987-P | Blood Utilization Audit during an Acute Shortage at a Tertiary Cardiac Centre | Mohd Afizul Afif Mohd Yusoff | |
| 988-P | Effectiveness and Utilization of Intravenous Ferric Derisomaltose in a Patient Blood Management Approach: A Two-Year Single-Center Experience | Mohamed Fikri Daud | |
| 989-P | EFFECTIVENESS OF INTRAVENOUS IRON UTILIZATION AT A SINGLE HOSPITAL SETTING | Nur Aklina | |
| 990-P | Impact of preoperative intravenous iron on haemoglobin levels and blood transfusion requirements in orthopaedic surgery | Jaya Rutrambigai Rajendran | |
| 991-P | COVID-19 Restrictions Reinforced PBM-Aligned Blood Ordering Behavior: A Whole-Hospital BBIS Cohort Study from a Malaysian Tertiary Hospital Hospital Tengku Ampuan Rahimah, Klang, Selangor, Malaysia | arif azhar | |
| 992-P | Effect of Acute Normovolemic Hemodilution on Allogeneic Blood Transfusion in Adult Cardiac Surgery: A Systematic Review and Meta-analysis | Yuwei Hu | |
| 993-P | Effectiveness of a Multidisciplinary Quality Improvement Initiative for Patient Blood Management in a Resource-Constrained Setting | Pallavi Singh | |
| 994-P | Optimizing Patient Blood Management in Post RYGB Patients: Insights from a Case of Severe Iron Deficiency Anemia | Nurul Afifah Mohd Yusoff | |
| 995-P | Post-Issue Returned Blood Components as a Patient Blood Management Quality Indicator: A Retrospective Study | Srinivasa Rao Chunchu | |
| 997-P | From Concept to Clinic: Operationalizing PBM Through PAM/PTHM and Platelet/Fibrinogen Pathways | Chixiang Liu | |
| 998-P | Preoperative intravenous iron clinic as a Patient Blood Management (PBM) modality in a tertiary center | Ummi Nurafifah Khairani Razali | |
| 999-P | Outcomes of Preoperative Intravenous Iron in Surgical and Orthopaedic Patients with Iron Deficiency Anaemia at Hospital Sultan Idris Shah, Serdang | Nur Zafirah Mohd Kamaludin | |
| 1000-P | QUALITY OF LIFE AND RELATED FACTORS IN ADULT TUNISIAN PATIENTS WITH TRANSFUSION-DEPENDENT ?-THALASSEMIA | Bouzaiene Marwa | |
| 1005-P | Outcomes of cardiac surgery patients treated with and without postoperative iron therapy in a cardiac centre, Hospital Serdang | Nurhazfizah Ali | |
| 1011-P | Transfusion practices in cardiac surgery patients: a single-center study (2021–2022) | NTOUKOLI ANASTASIA &913;&925;&913;&931;&932;&913;&931;&921;&913; | |
| 1013-P | Inherited a- and ß-globin variants in Taiwanese stroke patients: prevalence, transfusion implications, and patient blood management strategies. | Shin-Yi Tsai | |
| 1021-P | A Retrospective Audit of Intravenous Iron Utilization as a Core Strategy for Patient Blood Management at Hospital Shah Alam, Malaysia (2023-2025) | Norasrina binti Ishak | |
| 1023-P | IMPORTANCE OF ANTENATAL SCREENING IN EARLY DETECTION OF PARTIAL D VARIANT AMONG INDIGENOUS PENAN PREGNANT WOMEN | Nur Aklina | |
| 1028-P | Platelet Refractoriness Predicts Early Allograft Dysfunction in Living Donor Liver Transplantation: A Prospective Cohort Study | Deepti Sachan | |
| 1034-P | Granulocyte Support Using Pooled Buffy Coat Concentrates in Hematologic Malignancies: A Clinical Perspective | Ashish Jain | |
| 1036-P | Unmasking iron deficiency in polycythemia: diagnostic performance of reticulocyte hemoglobin content | Noufal Hussain R | |
| 1037-P | Monitoring of biochemical and hematological parameters in 93 transfused patients at the University Clinics of Bukavu (C.U.B) and at the Salama Polyclinic (P.S), East of the DRC. | Promesse Muhubao Bahati | |
| 1039-P | High Frequency of Pathogenic G6PD Variants in a Taiwanese Stroke Cohort: Transfusion Safety Implications and Donor-Unit Risk Stratification | Shin-Yi Tsai | |
| 1043-P | Standardising Cellular Banking, Histocompatibility Use, and Storage-Lesion Monitoring to Improve Transfusion Safety and Cell-Product Quality | SUVAM BANERJEE | |
| 1046-P | Optimization of Hematopoietic Stem Cell Storage and Cryobank Capacity Management in a High-Volume Transplant Center | Andrei Kolesov | |
| 1047-P | CXCR4 expression profiles in patients undergoing autologous peripheral blood stem cell mobilization with G-CSF and plerixafor: Immunological characteristics of poor mobilizers | Yukie Tanaka | |
| 1049-P | RBC DEPLETION IN MAJOR ABO-INCOMPATIBLE PERIPHERAL BLOOD STEM CELL TRANSPLANTS USING MODIFIED HYDROXYETHYL STARCH PROTOCOL | Amit Ajay Pawar | |
| 1050-P | FACTORS INFLUENCING INTENTION TO DONATE HAEMATOPOIETIC STEM CELLS AMONG BLOOD DONORS IN NATIONAL BLOOD CENTRE, KUALA LUMPUR | Isya Anwar Malik | |
| 1052-P | The therapeutic value of cord blood: from life-saving transplantation to regenerative medicine | Giuseppa Tancredi | |
| 1054-P | Fixed-dose pegfilgrastim enables reliable single-day peripheral blood stem cell collection in healthy allogeneic donors | Tomoshige Shimizu | |
| 1056-P | Beyond ABO: Apheresis bone marrow processing for red cell depletion for Rh(D) and Kidd incompatibilities in allogeneic bone marrow transplantation | Ahmad Makmom Muhammad Amir Rasyid | |
| 1058-P | Evaluation of CD34+ Stem Cell Collection and Engraftment Efficiency (2024 Audit) | Pabasara Premarathne | |
| 1059-P | Peripheral blood stem cell apheresis in low-weight pediatric patients (< 15kg). | ALIAKSEI LIPNITSKI | |
| 1061-P | IFN-γ as a Biomarker for Predicting Pain Events during Peripheral Blood Stem Cell Mobilization with G-CSF in Related Donors | Momoka Inomata | |
| 1062-P | Establishing a National Peripheral Blood Stem Cell Collection Program for Autologous Transplantation in Montenegro: First-Year Experience | Tamara Šcepanovic | |
| 1065-P | Comparative Impact of Cell Separators on Donor Hematological Parameters during Peripheral Blood Stem Cell Harvest | Pallavi Singh | |
| 1066-P | Predictors of Engraftment Success in Hematopoietic Stem Cell Collection: A Tertiary care centre experience. | Rengan Chandran Srinivasan | |
| 1069-P | Analysis of the proliferative potential of mesenchymal stem cells from different sources | Mariya Akhayeva | |
| 1071-P | Developing a low-cost platelet-rich-plasma (PRP) protocol treatment for wound healing in resource constrained areas: Case of Cameroon | BEUKOU FONKOU HYGIN STEVE | |
| 1072-P | Relevance of reporting Cytomegalovirus viral load below detection limit results in post haematopoietic stem cell transplant patients | Selvakumari Thrunavukarasou | |
| 1073-P | Efficacy and Safety of Granulocyte Transfusion in Paediatric Neutropenic Sepsis: A Single-Centre Case Series | Naqib Wazir | |
| 1081-P | Mapping HLA-A and -B antigen frequency in Patients with Platelet Transfusion Refractoriness against Platelet Donor Pool and General Population | Ailin Mazuita Mazlan | |
| 1083-P | Case Report of a Living Donor Renal Transplant in a Sensitized patient with pre-formed Donor-Specific Antibodies and Negative Crossmatches | Ganesan Aswinie | |
| 1084-P | CROSSMATCHING IN CADAVERIC RENAL TRANSPLANTATION: A FOUR-YEAR EXPERIENCE AT PUSAT DARAH NEGARA | Nurul Ainin Abdul Aziz | |
| 1085-P | Immunocomplex capture fluorescence analysis for donor selection in HLA-haploidentical peripheral blood stem cell transplantation | Takayo Sakurazawa | |
| 1086-P | Who´s Linked to Whom? Decoding HLA Haplotypes in the Laboratory | Low Hwei Yee | |
| 1093-P | Transfusion-Induced Immune Response Modulates Cuproptosis via SPP1 in Cholangiocarcinoma | Zhaohui Tang | |
| 1095-P | Association of ABO Blood Group Gene Expression with Advanced Lung Adenocarcinoma Cells and the Immune Microenvironment | zhe nian | |
| 1103-P | Impact of HFE Variants on Iron Overload in Transfusion-Dependent Beta-Thalassemia on Hb F Augmentation Therapy | Maeesa Wadood | |
| 1104-P | Distinct ABO Blood Group–Associated Chromatin Signatures in Hematopoietic Stem Cells | Romy Kronstein-Wiedemann | |
| 1111-P | Teletransfusiology as a means of communication with remote regions in conditions of a shortage of specialists | Irina Krobinets | |
| 1112-P | Automated Blood Bank Data Extraction Using RPA | Zuraini Arsad | |
| 1113-P | Implementation and Validation of an Enhanced NAT Discriminatory Module in a National Blood Bank Information System | Malisanurhidayu Yaacob | |
| 1115-P | Challenges in Implementing the ISBT 128 Standard in Low- and Middle-Income Countries | Shivanand Hemant Kumatagi | |
| 1116-P | Retrospective validation of an open-source web application for statistical process control of blood components | Hector Sarmiento Palao | |
| 1122-P | Data connectivity to monitor key performance indicators and operator productivity in whole blood automation processing | Manuel Gutiérrez de Ravé | |
| 1126-P | Real World Evidence on the prevalence of immunosuppression and liver disease in blood transfusion recipients | Igor Rossa-Ramm | |
| 1131-P | Preoperative Prediction of Platelet Transfusion Requirements in Open-Heart Valve Replacement: A Stacking Ensemble Machine Learning Approach | Yuki Hatayama | |
| 1133-P | Formation of a dataset for training prognostic AI models in blood donation based on standardized donor data | Irina Krobinets | |
| 1135-P | Next-Generation Hemovigilance: Integrating Multi-Parameter Data Through Artificial Intelligence to Predict Transfusion Reactions | Arif Pamujumadi | |
| 1136-P | Precision Transfusion Medicine: Artificial Intelligence Prediction of Platelet Transfusion Refractoriness in Hematologic Malignancies | Yama Sirly Putri | |
| 1140-P | Using artificial intelligence as a cognitive assistant to plan and execute a transfusion medicine conference | ARUN V J | |
| 1142-P | Implementing an AI Assistant to Streamline Bloodbank administrative guidance and knowledge management: A Pilot Study | Muhammad Faizal Bin Sahari | |
20-24 June, 2026 Kuala Lumpur

Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|
|